Jason Valent, MD of Cleveland Clinic talks about daratumumab in multiple myeloma at the 58th ASH Annual Meeting in San Diego, CA.
Daratumumab Combination Studies are a Big Improvement over Previous Results
Jason Valent, MD of Cleveland Clinic talks about daratumumab in multiple myeloma at the 58th ASH Annual Meeting in San Diego, CA.